MedPath

Ridge Preservation Comparing 2 Membranes

Not Applicable
Completed
Conditions
Alveolar Ridge Deficiency
Interventions
Procedure: Acellular dermal matrix
Procedure: Non-resorbable membrane
Registration Number
NCT01905280
Lead Sponsor
University of Louisville
Brief Summary

The purpose of this study is to compare the clinical and histologic outcomes for acellular dermal matrix and a nonresorbable membrane to determine if either provides a significant therapeutic advantage. The hypothesis is that there will be no difference in crestal ridge width between the two treatments.

Detailed Description

30 patients will be selected that meet the following criteria:

Inclusion Criteria

1. Have one non-molar tooth requiring extraction that will be replaced by a dental implant. The site must be bordered by at least one tooth.

2. Healthy male or female who is at least 18 years old.

3. Patients must sign an informed consent approved by the University of Louisville Human Studies Committee.

Exclusion Criteria

1. Patients with debilitating systemic diseases, or diseases that have a clinically significant effect on the periodontium.

2. Presence or history of osteonecrosis of jaws.

3. Patients who are currently taking IV bisphosphonates or who had IV treatment with bisphosphonates irrespective of duration.

4. Patients who have been treated with oral bisphosphonates for more than three years.

5. Patients with an allergy to any material or medication used in the study.

6. Patients who need prophylactic antibiotics.

7. Previous head and neck radiation therapy.

8. Chemotherapy in the previous 12 months.

9. Patients on long term NSAID or steroid therapy.

10. Pregnant patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  1. Have one non-molar tooth requiring extraction that will be replaced by a dental implant. The site must be bordered by at least one tooth.
  2. Healthy male or female who is at least 18 years old.
  3. Patients must sign an informed consent approved by the University of Louisville Human Studies Committee.
Exclusion Criteria
  1. Patients with debilitating systemic diseases, or diseases that have a clinically significant effect on the periodontium.
  2. Presence or history of osteonecrosis of jaws.
  3. Patients who are currently taking IV bisphosphonates or who had IV treatment with bisphosphonates irrespective of duration.
  4. Patients who have been treated with oral bisphosphonates for more than three years.
  5. Patients with an allergy to any material or medication used in the study.
  6. Patients who need prophylactic antibiotics.
  7. Previous head and neck radiation therapy.
  8. Chemotherapy in the previous 12 months.
  9. Patients on long term NSAID or steroid therapy.
  10. Pregnant patients.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Acellular dermal matrixAcellular dermal matrixA ridge preservation graft will be performed and then covered using acellular dermal matrix as a membrane.
Non-resorbable membraneNon-resorbable membraneA ridge preservation graft will be performed and then covered using a non-resorbable PTFE membrane.
Primary Outcome Measures
NameTimeMethod
Crestal ridge width4 months

The width of the ridge at the crest will be measured with a digital caliper.

Secondary Outcome Measures
NameTimeMethod
Percent vital bone4 months

Percent vital bone at the graft site will be determined from a trephine core sample.

Trial Locations

Locations (1)

Graduate Periodontics Clinic University of Louisville

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath